MSKCC in the News: February 9 – February 23

 

  • ScienceInsider reported on a petition drafted by Robert Benezra at MSKCC that urges NIH to reconsider grant application rules that limits the number of times an applicant can submit a revised version of a grant application only once instead of twice.
  • Pharmaceutical Business Review recently announced a Phase 2 clinical trial sponsored by The Ludwig Institute for Cancer Research (LICR) evaluating the effectiveness of ADI-PEG 20 in the treatment of small cell lung cancer (SCLC) that will take place at MSKCC and Duke University Medical Center.
  • Dr. Scher of MSKCC announced at the fourth annual Genitourinary Cancers Symposium that an investigational drug called abiraterone acetate may help men with hard to treat prostate cancer.
  • Blog Buzz: February 12 – 18

    Roundup of interesting news from the medical library, oncology, life sciences and informatics blogosphere:

    • iPad radiology app wins FDA approval in breakthrough for mobile imaging.
    • New trends in public/private drug development partnerships received some press this week: Facultyof1000 as well as open data advocate John Wilbanks both weighed in on the findings of a New England Journal of Medicine article on the topic.
    • Elsevier has developed a new SciVerse app for oncologists called My Oncology Articles. “My Oncology Articles application tracks and displays articles from Elsevier’s 20+ leading oncology journals on a bi-weekly basis.” via MDAnderson Cancer Center Library’s NewsBytes.
    • MassGenomics posted about a new study from the Sanger Institute that documented a phenomenon called chromothripsis, in which hundreds of cancer-causing chromosomal rearrangements occur in a one-time cellular crisis, rather than progressively over time.
    • The Dirty Little Secrets of Search (and why you might want to Ask a Librarian to help you find the most current and evidence-based research).